Back to UBS Group AG UBS Group AG

TECHTECH
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in BIO-TECHNE CORP

UBS Group AG holds 2.5M shares of TECH (BIO-TECHNE CORP), worth $175.1M as of 2026-Q2. The position was decreased (-18.9% shares). TECH represents 0.0% of UBS Group AG's portfolio.

Current Value

$175.1M

Current Shares

2.5M

Total Value Change

+$153M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.5M
-18.9%
$175.1M0.0%$70.65
0
2026-Q1
Increased
3.1M
+37.3%
$159.6M0.0%$56.99
40
2025-Q4
Increased
2.2M
+47.4%
$130.8M0.0%$59.04
41
2025-Q3
Increased
1.5M
+52.1%
$84M0.0%$52.09
42
2025-Q2
Decreased
992,386
-47.0%
$51.1M0.0%$51.62
0
2025-Q1
Increased
1.9M
+157.5%
$109.9M0.0%$58.39
48
2024-Q4
Increased
727,805
+163.4%
$52.4M0.0%$71.78
47
2024-Q3
Increased
276,346
+12.3%
$22.1M0.0%$78.09
32

Other major holders of TECH: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used